Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
J Biol Chem ; 288(15): 10792-804, 2013 Apr 12.
Artigo em Inglês | MEDLINE | ID: mdl-23430260

RESUMO

Small conductance calcium-activated potassium (SK2/K(Ca)2.2) channels are known to be located in the neuronal plasma membrane where they provide feedback control of NMDA receptor activity. Here, we provide evidence that SK2 channels are also located in the inner mitochondrial membrane of neuronal mitochondria. Patch clamp recordings in isolated mitoplasts suggest insertion into the inner mitochondrial membrane with the C and N termini facing the intermembrane space. Activation of SK channels increased mitochondrial K(+) currents, whereas channel inhibition attenuated these currents. In a model of glutamate toxicity, activation of SK2 channels attenuated the loss of the mitochondrial transmembrane potential, blocked mitochondrial fission, prevented the release of proapoptotic mitochondrial proteins, and reduced cell death. Neuroprotection was blocked by specific SK2 inhibitory peptides and siRNA targeting SK2 channels. Activation of mitochondrial SK2 channels may therefore represent promising targets for neuroprotective strategies in conditions of mitochondrial dysfunction.


Assuntos
Ácido Glutâmico/metabolismo , Mitocôndrias/metabolismo , Membranas Mitocondriais/metabolismo , Neurônios/metabolismo , Canais de Potássio Ativados por Cálcio de Condutância Baixa/metabolismo , Animais , Linhagem Celular , Membrana Celular/genética , Membrana Celular/metabolismo , Membrana Celular/patologia , Ácido Glutâmico/genética , Ácido Glutâmico/farmacologia , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Potencial da Membrana Mitocondrial/genética , Camundongos , Mitocôndrias/genética , Mitocôndrias/patologia , Membranas Mitocondriais/patologia , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Neurônios/patologia , Fármacos Neuroprotetores/farmacologia , Peptídeos/farmacologia , Potássio/metabolismo , Canais de Potássio Ativados por Cálcio de Condutância Baixa/antagonistas & inibidores , Canais de Potássio Ativados por Cálcio de Condutância Baixa/genética
2.
Brain Behav Immun ; 24(5): 831-8, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19961923

RESUMO

Mitochondria are highly dynamic organelles that undergo permanent fusion and fission, a process that is important for mitochondrial function and cellular survival. Emerging evidence suggests that oxidative stress disturbs mitochondrial morphology dynamics, resulting in detrimental mitochondrial fragmentation. In particular, such fatal mitochondrial fission has been detected in neurons exposed to oxidative stress, suggesting mitochondrial dynamics as a key feature in intrinsic death pathways. However, the regulation of mitochondrial fission in neurons exposed to lethal stress is largely unknown. Here, we used a model of glutamate toxicity in HT-22 cells for investigating mitochondrial fission and fusion in neurons exposed to oxidative stress. In these immortalized hippocampal neurons, glutamate induces glutathione depletion and increased formation of reactive oxygen species (ROS). Glutamate toxicity resulted in mitochondrial fragmentation and peri-nuclear accumulation of the organelles. Further, mitochondrial fission was associated with loss of mitochondrial outer membrane potential (MOMP). The Bid-inhibitor BI-6c9 prevented MOMP and mitochondrial fission, and protected the cells from cell death. In conclusion, oxidative stress induced by glutamate causes mitochondrial translocation of Bid thereby inducing mitochondrial fission and associated mitochondrial cell death pathways. Inhibiting regulators of pathological mitochondrial fragmentation is proposed as an efficient strategy of neuroprotection.


Assuntos
Proteína Agonista de Morte Celular de Domínio Interatuante com BH3/metabolismo , Núcleo Celular/metabolismo , Mitocôndrias/metabolismo , Neurônios/metabolismo , Análise de Variância , Animais , Apoptose/efeitos dos fármacos , Apoptose/fisiologia , Linhagem Celular , Núcleo Celular/efeitos dos fármacos , Células Cultivadas , Técnicas de Transferência de Genes , Ácido Glutâmico/metabolismo , Ácido Glutâmico/farmacologia , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Imuno-Histoquímica , Mitocôndrias/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Espécies Reativas de Oxigênio/metabolismo
3.
Am J Pathol ; 173(6): 1795-805, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18988795

RESUMO

Traumatic brain injury (TBI) consists of two phases: an immediate phase in which damage is caused as a direct result of the mechanical impact; and a late phase of altered biochemical events that results in delayed tissue damage and is therefore amenable to therapeutic treatment. Because the molecular mechanisms of delayed post-traumatic neuronal cell death are still poorly understood, we investigated whether apoptosis-inducing factor (AIF), a pro-apoptotic mitochondrial molecule and the key factor in the caspase-independent, cell death signaling pathway, plays a causal role in neuronal death following TBI. Using an in vitro model of neuronal stretch injury, we demonstrated that AIF translocated from mitochondria to the nucleus of neurons displaying axonal disruption, chromatin condensation, and nuclear pyknosis in a caspase-independent manner, whereas astrocytes remained unaffected. Similar findings were observed following experimental TBI in mice, where AIF translocation to the nucleus coincided with delayed neuronal cell death in both cortical and hippocampal neurons. Down-regulation of AIF in vitro by siRNA significantly reduced stretch-induced neuronal cell death by 67%, a finding corroborated in vivo using AIF-deficient harlequin mutant mice, where secondary contusion expansion was significantly reduced by 44%. Hence, our current findings demonstrate that caspase-independent, AIF-mediated signaling pathways significantly contribute to post-traumatic neuronal cell death and may therefore represent novel therapeutic targets for the treatment of TBI.


Assuntos
Fator de Indução de Apoptose/metabolismo , Lesões Encefálicas , Morte Celular/fisiologia , Neurônios/fisiologia , Transporte Ativo do Núcleo Celular/fisiologia , Animais , Fator de Indução de Apoptose/genética , Lesões Encefálicas/metabolismo , Lesões Encefálicas/patologia , Caspases/metabolismo , Células Cultivadas , Criança , Ativação Enzimática , Humanos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Mutantes , Mitocôndrias/metabolismo , Neurônios/citologia , RNA Interferente Pequeno/genética , RNA Interferente Pequeno/metabolismo , Transdução de Sinais/fisiologia , Estresse Mecânico , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA